Casimersen

(Amondys 45®)

Amondys 45®

Drug updated on 12/19/2023

Dosage FormInjection (intravenous; 100 mg/2 mL)
Drug ClassAntisense oligonucleotides
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping.